Correction to: Pharmacokinetic and Pharmacodynamic Studies of Elacestrant, A Novel Oral Selective Estrogen Receptor Degrader, in Healthy Post-Menopausal Women

Detalles Bibliográficos
Autores principales: Conlan, Maureen G., de Vries, Erik F. J., Glaudemans, AWJM, Wang, Yamei, Troy, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511466/
https://www.ncbi.nlm.nih.gov/pubmed/32862369
http://dx.doi.org/10.1007/s13318-020-00638-0
_version_ 1783585961348694016
author Conlan, Maureen G.
de Vries, Erik F. J.
Glaudemans, AWJM
Wang, Yamei
Troy, Steven
author_facet Conlan, Maureen G.
de Vries, Erik F. J.
Glaudemans, AWJM
Wang, Yamei
Troy, Steven
author_sort Conlan, Maureen G.
collection PubMed
description
format Online
Article
Text
id pubmed-7511466
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-75114662020-10-05 Correction to: Pharmacokinetic and Pharmacodynamic Studies of Elacestrant, A Novel Oral Selective Estrogen Receptor Degrader, in Healthy Post-Menopausal Women Conlan, Maureen G. de Vries, Erik F. J. Glaudemans, AWJM Wang, Yamei Troy, Steven Eur J Drug Metab Pharmacokinet Correction Springer International Publishing 2020-08-30 2020 /pmc/articles/PMC7511466/ /pubmed/32862369 http://dx.doi.org/10.1007/s13318-020-00638-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correction
Conlan, Maureen G.
de Vries, Erik F. J.
Glaudemans, AWJM
Wang, Yamei
Troy, Steven
Correction to: Pharmacokinetic and Pharmacodynamic Studies of Elacestrant, A Novel Oral Selective Estrogen Receptor Degrader, in Healthy Post-Menopausal Women
title Correction to: Pharmacokinetic and Pharmacodynamic Studies of Elacestrant, A Novel Oral Selective Estrogen Receptor Degrader, in Healthy Post-Menopausal Women
title_full Correction to: Pharmacokinetic and Pharmacodynamic Studies of Elacestrant, A Novel Oral Selective Estrogen Receptor Degrader, in Healthy Post-Menopausal Women
title_fullStr Correction to: Pharmacokinetic and Pharmacodynamic Studies of Elacestrant, A Novel Oral Selective Estrogen Receptor Degrader, in Healthy Post-Menopausal Women
title_full_unstemmed Correction to: Pharmacokinetic and Pharmacodynamic Studies of Elacestrant, A Novel Oral Selective Estrogen Receptor Degrader, in Healthy Post-Menopausal Women
title_short Correction to: Pharmacokinetic and Pharmacodynamic Studies of Elacestrant, A Novel Oral Selective Estrogen Receptor Degrader, in Healthy Post-Menopausal Women
title_sort correction to: pharmacokinetic and pharmacodynamic studies of elacestrant, a novel oral selective estrogen receptor degrader, in healthy post-menopausal women
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511466/
https://www.ncbi.nlm.nih.gov/pubmed/32862369
http://dx.doi.org/10.1007/s13318-020-00638-0
work_keys_str_mv AT conlanmaureeng correctiontopharmacokineticandpharmacodynamicstudiesofelacestrantanoveloralselectiveestrogenreceptordegraderinhealthypostmenopausalwomen
AT devrieserikfj correctiontopharmacokineticandpharmacodynamicstudiesofelacestrantanoveloralselectiveestrogenreceptordegraderinhealthypostmenopausalwomen
AT glaudemansawjm correctiontopharmacokineticandpharmacodynamicstudiesofelacestrantanoveloralselectiveestrogenreceptordegraderinhealthypostmenopausalwomen
AT wangyamei correctiontopharmacokineticandpharmacodynamicstudiesofelacestrantanoveloralselectiveestrogenreceptordegraderinhealthypostmenopausalwomen
AT troysteven correctiontopharmacokineticandpharmacodynamicstudiesofelacestrantanoveloralselectiveestrogenreceptordegraderinhealthypostmenopausalwomen

Ejemplares similares